then last been you, the by early are healthy families operator and you your in hardship and and Thank disruption COVID-XX ago well. tragedy, good spoke We inflicted hope March. society months morning, Since extraordinary. everyone. I across two and broadly has
For commercial Stereotaxis, creativity, to navigate also progress period been approach we COVID-XX. from impact provide call, then but of been change. our to positive successfully it to On today's are the responding seeing this has are period will ways has we and I uncertainty. the I time the an discuss this and into invigorating challenges want challenging, transparency of
impact. customers pandemic. commercial the the with Stereotaxis' against the start are front in battle hospital Let's the line on
acute reaction, hospitals lessen procedure to pandemic. order vital battling an risk, towards dramatically have preserve resources in and infection volumes equipment reduced the focus globally their As
volumes not to been With that immune to broad has is medical surveys procedure documenting typically various be XX% not would in reduction of procedures The field The XX% electrophysiology of procedure a in those reductions unprecedented. range including considered declines. elective. these
procedure March, experienced with of first volumes North through Up were week Europe we consistent America in the expectations. and that
impact overall isolated to prior been was Our the procedure was but XX% year, in that down compared over and our decline global to modest the had Asia business. volume China to
across not entirely. steep ablation decline was we Europe of customers see started the week approximately perform a that half of stopping of performed volumes felt XX% did their procedures sudden Over other April. March second The first deceleration and the half America to in hospitals procedures across curtailing most first severely in normal. levels to the with and procedures procedure of below half any March, and procedures our in North hospital In
Stereotaxis in these of decrease The the due volume recurring to across earns disposables in revenue the approximately revenue quarter from first majority in geographies. in observed of the recurring half used was its procedures. procedure decline
We have a begun an gradual to pandemic and to of of the feel to as better -- return see extended patient hospitals both indications shutdown battle activity and on hospital -- health prepared
steps down to that levels. Our have April procedure European delineated has returned in and U.S. volume in for Several entirely almost reopening pre-COVID partial in China shut hospitals were May.
a large conclusions for months that reduced hopeful in we and with estimate the duration are are as we to While procedure cautious persist with confidence. return volatility there data short-term for remains The numbers. expectation drawing procedure of the recovery of slope will daily impossible activity, several is activity from in
In on a addition to our the to temporary end at the procedures, travel restrictions had complete certain the acute activities impact on quarter. of service first ability impact
typical long-term earned of quarter contracts. XX% revenue covered by is contracts, about service majority the While a service from vast of not is in from our billings earned project-specific revenue service
revenue, Not the That in decline being on of two able to specific timing. observed in accounted the not such first complete for XX% revenue is projects work lost issue of rather quarter. an but
negative over this projects quarter. restarted surprises, days them complete expect last service the any those have We few to we and barring
stability source driven largely our non-cancelable half comprises of Service revenue protected as just from for We primarily a and recurring of contracts. revenue view COVID-XX. and Stereotaxis multiyear this is over revenue by
Genesis system. robotic were of We March FDA announce proud to clearance in novel early our
and had would we negotiation. stages were were growth we several customers Genesis. purchase already confident of in additional projection that late existing this We new both approval, and On that orders see of the that revenue to year heels as orders were adoption significant driven in there received projected that two of by
purchase orders received interruption. the already on Progress that continues were two without
is The ship to revenue the and first and system are in to this weeks. coming early is in Both installed expected transit system the as be we to expected recorded Europe speak as summer. second
The has the purchase on progress the to expected pandemic several disrupted be call. announce on orders able to unfortunately we this
return continue very can to on delays Genesis. we feedback the system continue be and positive cycle indefinitely projects inbound recedes. delayed, disappointing, sales we as robotic While but are Replacement to a expect receive to pandemic the not interest robust and
we are impact COVID-XX The from observing outside control. our of largely is
fully to responsibility. the navigate this way has though, and new the of the we proud period, Stereotaxis our team realities. challenges how and I'm response adapted is Our rapidly
Our primary the financial stability the patients of been on and been and efficient technology, maintaining have operations, goals continued in supporting innovations rapid during maintaining rely that smooth on our company. progress protecting expand each. -- has ensuring will physicians and strategic briefly this I our period the
treat used to world, suffering dangerous daily all physicians is technology Stereotaxis' around physicians. and arrhythmias. patients by supporting patients from First, the
technology cannot well patients delivered treated plays in or role treatment be who be effectively treating key all, Our at in enabling and and a to robotics. safely without
our and the technical support clinical continue responsibility physicians to to hospitals on rely and recognize We us. that providing
support connectivity capability. complemented We Stereotaxis' remotely, procedures members technology. robotic of build-out proprietary now using support, have a with in-person Dozens an our support of aggressive team telerobotic
has accessed screen telemedicine is needed procedure secured platform be afar controlled lab remotely viewed aggregate established through Robotics if then and from display to Stereotaxis and cath that an display for that capabilities allow all one unique networks. for and on information ideal large
the last We have and use acceptance seen interest support broad telerobotics of over weeks.
a support technology ago remotely supported our sales our southeastern directors was telerobotic used, no complications the one treating weeks of fluoroscopy women a pregnant the a baby was dangerous tachycardia. successful, not harmed. of physician U.S. so had and who XX-week in was a was highlighted our importance The when The capability no procedure few with and was ventricular
role, technology the an take and important We that continue a on on support will expect increasingly to perform COVID-XX. post telerobotic basis daily even
key open pioneering with an capabilities robotic maintain as advance cornerstone of be need are hand technology, and We to our sharing continue during to surgery. to a we'll others time of this telerobotics proud this
transitioning despite the immense operations, across particularly of and efficiently the our to required want of significant team from working team to thank I for home, has collaborating IT our the rising enabling a smooth majority effectively, to organization. rapidly effort challenge continue Maintaining team vast to distributed safely.
company across operations the aspects Our of all interruption. functioned have without
of supply and We to engage managing we with believe partners continue supply inventory. the our well are key chain
has and to committed passionate advancing team new mission. adapted the to Our remains creatively environment and Stereotaxis'
From and receive our a accommodating office, or Genesis take we and system live headquarters, with home demonstration physicians tour system, an in viewing of catheter interests are continue Genesis launched interested a a our physician of direct in As drive order example, Genesis. test to to drives. control telerobotic the able their
increased three times Over said I've there's of team. often day crisis, I individual change that appreciation this is openness last the possible. and tours hosted for see weeks It is our increased of during across physicians to hospitals. XX XX ingenuity, every from what
to recently received refinements catheter KOLs were several optimize performance. Osypka continue phantom. to teams make make spoke progress drives who receive with our ago, navigate in innovations. the a prototypes Most refined feedback here telerobotic last Stereotaxis continued the on catheter. We months two magnetic progress test to strategic able to our minor ablation importantly to to we next-generation from We catheter and leveraged Since and have is the design
focused glowing stage look us into provided is reviews transitioning KOLs improve design clinical design performance on and outcomes. and the the processes. how expected The near-term We to next finalizing the on refining the navigation manufacturing the the with to and forward in establishing
preparing regulatory a begun In efforts, strategy U.S. trial. our strategy tandem with and engineering clinical for Europe we've the IDE for
and is second significant magnetic that within of wave larger to innovation, redefine EP of innovation, on beyond. efforts continue a its me -- and time Beyond Stereotaxis confidence the ablation R&D meaningfully catheter enhance navigation creatively accessibility. ways in project team robotic capabilities and These amounts having -- gives spending the both
times, As particularly particularly important for has reduction in at robotic financial is disposable important is Stereotaxis black helpful It of stability delays weather but Stereotaxis. Financial revenue all now. prudence like described important to of of is sales. on management the earlier, Financial Stereotaxis. events felt and and shocks all been our for the businesses, swan a but the system impact of hallmark of in primarily COVID-XX
and need to partners physician that investing feel equipment trajectory need our a be to industry comfortable in customers be partner. and Strategic Our confident long-term as hospital will many in years. for used reliability
are implications, it's worked for us able extended it us an confidently of expenses we to on none that a the Accordingly, time. plan incumbent While organization. extended persist disruption is economic of hard across for period the reduce and trajectory of have -- pandemic, to will broad the to its estimate
not does slow harm this capabilities fashion doing that progress. surgical are organizational in We our and maintains delicate our a or
which Protection I Kim and otherwise them forgivable the additional funding $X.X us the has want to hard loan. and in avoid their million worked and reductions navigating been team would to Paycheck efforts, necessary. expenses receive That have application helped thank a us finance allowed congratulate Program that in
of process relief pursuing European modest more similar the in various are We from countries.
the pass the comments a we'll to and few then Q&A. call make over Kim I results final I'll discuss open financial our call will now and in detail to more to Kim?
